Adimab
Rebecca Hurley Niles has worked in the scientific field since 2008. Rebecca began as a Post-doc at Dartmouth Medical School in 2008, and then moved to Adimab in 2009, where they held the role of Scientist.
Rebecca Hurley Niles earned a PhD in Biochemistry from Dartmouth College between 2001 and 2006. Prior to that, they obtained a BS in Biology from Brandeis University between 1995 and 1999.
Adimab
1 followers
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.